Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Army
Cantor Fitzgerald
Argus Health
Chubb
US Department of Justice

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 7,709,477

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,709,477
Title:Methods for treating cancer
Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
Inventor(s): Attardo; Giorgio (Vimont, CA), Lavallee; Jean-Francois (Mille-Iles, CA), Rioux; Elise (Laval, CA), Tripathy; Sasmita (Pierrefonds, CA), Doyle; Terrence W. (Killingworth, CT)
Assignee: Gemin X Pharmaceuticals Canada Inc. (Montreal, CA)
Application Number:12/176,161
Patent Claims:see list of patent claims

Details for Patent 7,709,477

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial Gemin X Pharmaceuticals Canada Inc. (Montreal, CA) 2024-05-28 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Moodys
US Army
Argus Health
Citi
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.